Status:

COMPLETED

Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives

Lead Sponsor:

Odense University Hospital

Conditions:

Uterine Fibroids

Arterial Embolization

Eligibility:

FEMALE

18-52 years

Phase:

NA

Brief Summary

The purpose of this prospective non-randomised study is to examine whether two different microspheres (Bead-Block and Embosphere) are equally effective in the treatment of the uterine fibroid controll...

Detailed Description

Group 1: 26 patient will be treated with Bead-block microspheres - 700-900 µm microspheres or combinations of one vial 2 ml of 500-700 µm microspheres, follow by 700-900 µm microspheres until blood fl...

Eligibility Criteria

Inclusion

  • symptomatic uterus fibroma

Exclusion

  • pelvic infection (cystitis, oophoritis, salpingitis, abscess, urethritis)
  • gravidity
  • uterus malignancy
  • big subserosal fibroma with stalk diameter of \<2 cm
  • menopausal women
  • don,t want to be included into the study
  • concomitant adenomyosis

Key Trial Info

Start Date :

November 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2016

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT01852734

Start Date

November 1 2013

End Date

April 1 2016

Last Update

November 28 2016

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Odense University Hospital

Odense, Denmark, Denmark, 5000

2

Odense University Hospital

Odense, Fyn, Denmark, 5000

Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | DecenTrialz